Inquiries · Recommendations
Recommendations: Infected Blood Inquiry
1,814 tracked recommendations
35 inquiries
74 match current filters
Page 1 of 2
Recommendations issued by UK statutory and non-statutory inquiries, with their tracked government response and supporting evidence.
Recommendations
| Code | Recommendation | Inquiry | Response |
|---|---|---|---|
| AC-1a |
Open Registration
The scheme be opened to registration to everyone who may be eligible.
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1b |
Registration and Application Forms
There be forms (devised by IBCA) for people to register and apply for a core award and the supplementary awards with/without the …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1c |
Legal Support Signposting
IBCA include a prominent reference to the availability of legal support paid by IBCA on all registration and application forms and in …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1d |
Three-Cohort Prioritisation
When IBCA opens up the service beyond people infected and registered with the support schemes, IBCA: (i) update the sequencing to three …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1e |
Oral Representations at Review
IBCA consider making provision, either generally or in specific cases, for oral representations to be made where a decision is reviewed internally, …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1f |
Written Reasons for Decisions
Written reasons for the original decision must be provided so that the review process can operate fairly.
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2a |
Publish Guidance and Board Minutes
IBCA should publish: guidance, advice or instructions to claim managers; work undertaken by IBCA with the Cabinet Office's policy team to ensure …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2b |
Share Clinical Assessor Advice
In respect of any case in which the advice of a clinical assessor has been given, in relation to the person concerned …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2c |
Community Advisory Body
A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2d |
Structured Response to Community Input
To build confidence that IBCA is actively listening to people infected and affected, IBCA adopt more of a structured response to contributions …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-2e |
Transparency of Scheme Design
The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-3a |
HIV Eligibility Start Date
An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-4c |
Effective Treatment - Earnings Floor
For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-4d |
Deeming of Severity Bands
Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-4e |
Evidence of Diagnosis Date
Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-8b |
Affected Estates
The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-9a |
Bereaved Partner Support Scheme
The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-1 |
Compensation Scheme
My principal recommendation remains that a compensation scheme should be set up now
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-2a |
UK and Devolved Memorials
A permanent memorial be established in the UK and consideration be given to memorials in each of Northern Ireland, Wales and Scotland. …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-2b |
Treloar's School Memorial
A memorial be established at public expense, dedicated specifically to the children infected at Treloar’s school. The memorial should be such as …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-2c |
Community Support Events
There should be at least three events, approximately six months apart, drawing together those infected and affected, the nature and timing of …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-3a |
Medical Education - Curriculum
The General Medical Council, and NHS Education for Scotland, Health Education and Improvement Wales, Northern Ireland Medical and Dental Training Agency and …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-3b |
Medical Education - Training Materials
They should look favourably upon putting together a package of training materials, with excerpts from oral and written testimony, to underpin what …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-3c |
Inquiry Website Preservation
The Inquiry website is maintained online
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(i) |
Duty of Candour - Northern Ireland
Duty of candour: A statutory duty of candour in healthcare should be introduced in Northern Ireland.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(ii) |
Duty of Candour - Scotland and Wales Review
Duty of candour: The operation of the duties of candour in healthcare in Scotland and in Wales should be reviewed, as it …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(iii) |
Duty of Candour - England Review
Duty of candour: The review of the duty of candour currently under way in England should be completed as soon as practicable.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4c(i) |
Simplify External Regulation
Regulation: That external regulation of safety in healthcare be simplified. As a first step towards this, there should be a UK wide …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4c(ii) |
Safety Management Systems Coordination
Regulation: That the national healthcare administrations in England, Northern Ireland, Scotland and Wales explore, and if appropriate, support the development and implementation …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4d |
Patient Records Audit
Patient Records: Before the end of 2027 there should be a formal audit, publicly reported, of the extent of success of digitisation …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4e |
Cross-Administration Patient Safety Coordination
Coordination of patient records with devolved governments: Consideration should be given by the national healthcare administrations in England, Scotland, Wales and Northern …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(i) |
Hepatologist Oversight and Fibroscan Access
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have been …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(iii) |
Uncertainty About Fibrosis
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Where there is any …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(iv) |
Fibroscan for Liver Imaging
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Fibroscan technology should be …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(vi) |
Commissioning Hepatology Services
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those bodies responsible for …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7a(ii) |
Tranexamic Acid - Scotland, Wales and NI
In Scotland, Wales and Northern Ireland offering the use of tranexamic acid should be considered a treatment of preference in respect of …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7a(iii) |
Transfusion Performance Benchmarking
Consideration be given to standardising and benchmarking transfusion performance between hospitals in order to deliver better patient blood management
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7b |
Transfusion 2024 Review Progress
Review of progress towards the Transfusion 2024 recommendations: Progress in implementation of the Transfusion 2024 recommendations be reviewed, and next steps be …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7f(i) |
Transfusion Outcome Framework
Establishing the outcome of every transfusion: That a framework be established for recording outcomes for recipients of blood components. That those records …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7f(ii) |
NHSBT Transfusion Outcome Funding
Establishing the outcome of every transfusion: To the extent that the funding for digital transformation does not already cover the setting up …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-8a |
Pre-1996 Transfusion Testing
When doctors become aware that a patient has had a blood transfusion prior to 1996, that patient should be offered a blood …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-8b |
New Patient Registration Screening
As a matter of routine, new patients registering at a practice should be asked if they have had such a transfusion.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9a |
Haemophilia Peer Review
That peer review of haemophilia care should continue to occur as presently practised, with any necessary support being provided by NHS Trusts …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9b |
Trust/Board Action on Peer Reviews
That NHS Trusts and Health Boards should be required to deliberate on peer review findings and give favourable consideration to implementing the …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9c |
Five-Year Peer Review Cycle
A peer review of each centre should take place not less than once every five years.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9d |
Haemophilia Centre Resources
The necessary administrative and clinical resources should be provided by hospital trusts and boards, integrated care boards, and service commissioners to facilitate …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9e |
Recombinant Products Over Plasma-Derived
Recombinant coagulation factor products should be offered in place of plasma-derived ones where clinically appropriate. Service commissioners should ensure that such treatment …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9f |
National Haemophilia Database Support
That the National Haemophilia Database, run by the UKHCDO, merits the support of additional central funding.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-10a(i) |
Patient Satisfaction in Clinical Audits
A clinical audit should as a matter of routine include measures of patient satisfaction or concern, and these should be reported to …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-10a(ii) |
Charity Funding for Patient Advocacy
That the following charities receive funding specifically for patient advocacy: the UK Haemophilia Society; the Hepatitis C Trust; Haemophilia Scotland; the Scottish …
|
Infected Blood Inquiry (2024) | Accepted |
Page 1 of 2
Next ›